Is a Dense Mammographic Parenchymal Pattern a Contraindication to Hormonal Replacement Therapy?

References

• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108411 women without breast cancer. Lancet 1997; 350: 1047–59.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Stampfer MJ, Willett WC, Hennekens CH, Rosner B, Speizer FE. Prospective study of oestrogen replacement therapy and risk of breast cancer in postmenopausal women. J Am Med Assoc 1990; 264: 2648–53.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589–93.
   PubMed Web of Science ®Google Scholar
• Wolfe IN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976; 126: 1130–9.
   PubMed Web of Science ®Google Scholar
• Wolfe IN. Risk for breast cancer development determined by mammography parenchymal pattern. Cancer 1976; 37: 2486–92.
   PubMed Web of Science ®Google Scholar
• de Stavola BL, Gravelle IH, Wang DY, et al. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol 1990; 19: 247–54.
   PubMed Web of Science ®Google Scholar
• Warner E, Lockwood G, Tritchel D, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prey 1992; 16: 67–72.
   PubMedGoogle Scholar
• Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo P. A nested case-control study of mammographic patterns, breast volume and breast cancer (New York City, NY, United States). Cancer Causes Control 1995; 6: 431–8.
   PubMedGoogle Scholar
• Salminen T, Saarenmaa I, Heikki% M, Hakama M. Risk of breast cancer and changes in mammographic parenchymal patterns over time. Acta Oncol 1998; 37: 547–51.
   Google Scholar
• Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196: 433–7.
   PubMed Web of Science ®Google Scholar
• Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hor-mone replacement therapy: a longitudinal study. Radiology 1990; 174: 487–90.
   PubMed Web of Science ®Google Scholar
• Kaufman Z, Garstin WIH, Hayes R, Michell MJ, Baum M. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 1991; 43: 389–92.
   Google Scholar
• McNicholas MMJ, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP. Pain and increased mammog-arphic density in women receiving hormone replacement ther-apy: a prospective study. Am J Roentgenol 1994; 163: 311–5.
   PubMedGoogle Scholar
• Hakama M, Pukkala E, Kallio M, Godenhj elm K, Svinhufvud U. Effectiveness of screening for breast cancer in women under 50 years at entry: the Kotka pilot project in Finland. Int J Cancer 1995; 63: 55–7.
   Google Scholar
• Breslow NE, Day NE. Statistical methods in cancer research. Vol. II: The design and analysis of cohort studies. Lyon: IARC Scientific publications no. 82, 1987.
   Google Scholar
• Salminen T, Saarenmaa I, Heikki% M, Hakama M. Unfa-vourable change in mammographic parenchymal patterns and the breast cancer risk factors. Breast Cancer Res Tr 1999; 57: 165–73.
   Google Scholar
• Salminen T, Hakama M, Heikki% M, Saarenmaa I. Favorable change in mammographic parenchymal patterns and breast cancer risk factors. Int J Cancer 1998; 78: 410–4.
   PubMedGoogle Scholar
• Egan RL. Breast imaging: diagnosis and morphology of breast diseases. Philadelphia: W.B Saunders, 1988.
   Google Scholar
• Romrell LJ, Bland KI. Anatomy of the breast, axilla, chest wall, and related metastatic sites. In: Bland KI, Copeland EM, ed. The breast. Comprehensive management of benign and malig-nant diseases. Philadelphia: W.B. Saunders, 1991: 17–35.
   Google Scholar
• LaCroix AZ, Burke W. Breast cancer and hormone replacement therapy. Lancet 1997; 350: 1042–3.
   PubMed Web of Science ®Google Scholar
• Colditz GA. Relationship between oestrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998; 90: 814–23.
   PubMed Web of Science ®Google Scholar
• Laya MB, Larson EB, Taplin SH, White E Effect of oestrogen replacement therapy on the specificity and sensitivity of screen-ing mammography. J Natl Cancer Inst 1996; 88: 643–9.
   PubMed Web of Science ®Google Scholar
• Persson I, Thurfjell E, Holmberg L. Effect of oestrogen and oestrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997; 15: 3201–7.
   Google Scholar
• Topo P. Dissemination of climacteric and postmenopausal hormone therapy in Finland. Stakes. Research reports 78. Jyväskylä: Gummerus Kirjapaino Oy, 1997.
   Google Scholar
• Topo P, Hemminki E, Uutela A. Women's choice and physi-cians' advice on use of menopausal and postmenopausal hormone therapy. Int J Health Sciences 1993; 4: 101–9.
   Google Scholar
• Topo P, Klaukka T, Hemminki E, Uutela A Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women. J Epidemiol Community Health 1991; 45: 277–80.
   PubMed Web of Science ®Google Scholar